Navigation Links
MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
Date:9/11/2007

f 2008 and if the results of this trial are positive, Cadence submitting a new drug application (NDA) for Omigard in the first half of 2009; data from the celgosivir Phase II extension protocol being available by the end of 2007; 4-week interim results from the Phase II viral kinetics combination study of celgosivir in approximately 10 treatment-naive patients in October 2007; submitting an IND in the US in the first quarter of 2008 for the future development of celgosivir; Cutanea Life Sciences completing the Phase II CLS001 rosacea clinical trial in 2007; our estimate of the probable royalties payable to the holders of the convertible royalty participation units; the Company continuing to advance its highest priority programs while operating within an annual burn rate of $11 million to $13 million; and the Company's financial resources being sufficient to fund operations into the third quarter of calendar 2008.

With respect to the forward-looking statements contained in this news release, we have made numerous assumptions regarding, among other things: Cadence's ability to enroll sufficient patients to complete the Omigard CLIRS trial; the adequacy of the CLIRS trial design to generate data that are deemed sufficient by regulatory authorities to support potential regulatory filings, including an NDA, for Omigard; our ability to manage licensing opportunities; our ability to initiate, fund and complete non-clinical studies, clinical studies, manufacturing and all ancillary activities within our expected timelines; our partner Cutanea Life Sciences completing a Phase II CLS001 rosacea clinical trial in 2007; to and future expense levels being within our current expectations.

Actual results or events could differ materially from the plans, intentions and expectations expressed or implied in any forward-looking statements, including the underlying assumptions thereto, as a result of numerous risks, uncertainties and other factors including: dependence on c
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2015)... June 26, 2015  A San Francisco company, Pembient, ... with synthetic rhino horn: beer in China ... . In response to the emerging industry, two ... and sale of synthetic rhino horn.  ... Save the Rhino International (SRI) released a ...
(Date:6/26/2015)... , ... June 26, 2015 , ... ... services and a subsidiary of OraSure Technologies, Inc. (Nasdaq: OSUR) today announced that ... as part of its Gut Microbiome Grant Program. The company has awarded its ...
(Date:6/25/2015)... 25, 2015 ... announced the addition of the  "2015 ... Cancer Diagnostics Industry: Oncogenes, Biochemical Markers, ... Commercial Labs, POC Locations"  report ... (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , A ...
(Date:6/25/2015)... June 25, 2015  BioMed Realty Trust, Inc. (NYSE: ... ILMN ), a world leader in genomics focused ... the genome, has signed a 20-year lease for a ... in Cambridge, England . The project ... the highly skilled workforce in the dynamic research cluster ...
Breaking Biology Technology:Rhino Experts Oppose Synthetic Rhino Horn as Solution to Poaching Crisis 2DNA Genotek Inc. Announces Recipients of Gut Microbiome Grant Program 2DNA Genotek Inc. Announces Recipients of Gut Microbiome Grant Program 3Analysis of the Global Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains 2Analysis of the Global Cancer Diagnostics Industry 2015-2020: Oncogenes, Biochemical Markers, Lymphokines, GFs, CSFs, Hormones, Immunohistochemical Stains 3BioMed Realty And Illumina Announce New Build-To-Suit Laboratory Building In Cambridge's Growing Life Science Cluster 2BioMed Realty And Illumina Announce New Build-To-Suit Laboratory Building In Cambridge's Growing Life Science Cluster 3
... RNA Isolation Kit , Catalog #732-6370 , ... Method , ... Collect fresh virus and isolate RNA as , quickly as possible; store at ... -70 to -80C. , Cell Lysis , ...
... , , , AquaPure RNA Isolation Kit , ... Method , Cell Lysis ... Oak Ridge centrifuge , tube (or other tube rated for high speed) ... sputum, synovial fluid, , urine, whole blood). , ...
... Tuija Kekarainen and Jari P. T. Valkonen, Department of Plant Biology, Swedish,University of ... , Introduction ... method widely used for gene transfer , ... Shark et al. 1991, Williams et al. 1991, Zelenin et al. 1989). , ...
Cached Biology Technology:Total RNA Isolation: 100 l Viral Sample From Cultured-Cell Supernatant Containing Virus 2Total RNA Isolation From 500 l Body Fluid 2Inoculation of Viral RNA and cDNA to Potato and Tobacco Plants Using the Helios Gene Gun 2Inoculation of Viral RNA and cDNA to Potato and Tobacco Plants Using the Helios Gene Gun 3Inoculation of Viral RNA and cDNA to Potato and Tobacco Plants Using the Helios Gene Gun 4Inoculation of Viral RNA and cDNA to Potato and Tobacco Plants Using the Helios Gene Gun 5Inoculation of Viral RNA and cDNA to Potato and Tobacco Plants Using the Helios Gene Gun 6Inoculation of Viral RNA and cDNA to Potato and Tobacco Plants Using the Helios Gene Gun 7Inoculation of Viral RNA and cDNA to Potato and Tobacco Plants Using the Helios Gene Gun 8Inoculation of Viral RNA and cDNA to Potato and Tobacco Plants Using the Helios Gene Gun 9
(Date:6/25/2015)... SALT LAKE CITY , June 25, 2015 /PRNewswire/ ... the first steps toward a healthier, happier life. That,s ... app is designed to do. The cutting-edge, portable health ... and offers real-life solutions to help improve your lifestyle ... Sellers Association awards dinner and gala Wednesday night, USANA,s ...
(Date:6/24/2015)... YORK , June 24, 2015 The ... rate. The major drivers for the market include growth ... number of new drug launches. Over the years, the ... increased. Between 2001 and 2010, the FDA approved 225 ... according to WIPO, Europe accounted ...
(Date:6/24/2015)... SAN JOSE, Calif. , June 24, 2015 ... leading developer of human interface solutions, today announced ... fingerprint sensor to provide secure authentication for its ... Having recently reached more than 200 million shipments ... shipment with Sharp reinforces Synaptics, strength, scalability and ...
Breaking Biology News(10 mins):@USANAinc's Personalized Nutrition Program Wins Industry Innovation Award 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
... for Experimental Biology (FASEB) announces the opening of registration ... the Immune System. The 2013 FASEB Science Research ... be focusing on recent advances in our understanding of ... recent years, investigations aimed at understanding the innate and ...
... of American Societies for Experimental Biology (FASEB) announces the ... Arf and Rab Family G Proteins. The 2013 ... is an important and unique scientific conference in which ... organelle biogenesis will be explored within the context of ...
... 24 edition of PLOS Pathogens , Saint Louis University ... the University of Pittsburgh report a breakthrough in the pursuit ... virus. Researchers were able to measure and then block a ... advantage of known similarities with another major pathogen, HIV. ...
Cached Biology News:In a fight to the finish, Saint Louis University research aims knockout punch at hepatitis B 2In a fight to the finish, Saint Louis University research aims knockout punch at hepatitis B 3In a fight to the finish, Saint Louis University research aims knockout punch at hepatitis B 4In a fight to the finish, Saint Louis University research aims knockout punch at hepatitis B 5
... The Neural Stem Cell Expansion Kit - Neurosphere ... neural stem cell expansion as neurospheres in ... specially formulated N-2 Plus Media Supplement, which has ... K.K. et al . (1996) Genes & ...
DNase I (Deoxyribonuclease I) digests single- and double-stranded DNA to oligodeoxyribonucleotides. Ribonuclease activity has been reduced to non-detectable levels....
... E. coli strain containing an overproducing clone ... Reverse Transcriptase catalyzes the polymerization of DNA ... Full-length copies of large mRNAs, >10 kb, ... a much lower RNase H activity than ...
... RQ1 RNase-Free DNase is a preparation ... or double-stranded DNA to produce 3-hydroxyl ... use in applications where maintaining the ... DNase is qualified for use with ...
Biology Products: